Pharmacokinetic Investigation to Study the In Vivo Bioavailability of Thiolated Chitosan Based Repaglinide Buccal Tablets

Background: Repaglinide (REP) is an antihyperglycemic drug having low bioavailability due to its extensive first-pass metabolism. The present study aimed to develop and pharmacokinetic investigte the thiolated chitosan (TC) based buccal tablets of REP for improved bioavailability. Methods: TC was pr...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Raja Navamanisubramanian (Auteur), Raghunandan Nerella (Auteur), Shanmuganathan Seetharaman (Auteur)
Format: Livre
Publié: Tabriz University of Medical Sciences, 2020-12-01T00:00:00Z.
Sujets:
Accès en ligne:Connect to this object online.
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires